EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RNAC: Cartesian Therapeutics Inc

24 Dec 25 13:00
LAST:

6.760

CHANGE:
 0.33		OPEN:
6.410		HIGH:
6.830		ASK:
0.000		VOLUME:
83.2K
CHG(%):
5.13		PREV:
6.430		LOW:
6.410		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Dec 256.4106.8306.4106.760111.0K
23 Dec 256.7006.8426.4006.430172.4K
22 Dec 257.2307.2506.6906.720156.4K
19 Dec 257.4307.6017.1307.220297.6K
18 Dec 257.5007.7507.2107.360190.5K
17 Dec 258.2808.3607.3807.430160.1K
16 Dec 258.9308.9707.8558.290239.6K
15 Dec 258.5309.2308.4308.970291.0K
12 Dec 258.4408.7468.2008.520173.6K
11 Dec 257.8308.6207.7358.450177.7K

PROFILE

Name:Cartesian Therapeutics Inc
About:Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:7495 New Horizon Way, Frederick, MD, United States, 21703
Website:https://www.cartesiantherapeutics.com
CUSIP:816212104
CIK:0001453687
ISIN:US8162121045
FIGI:BBG001J19Q25
LEI:529900NMN0LACZOL7C43

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:1.98 
Forward P/E:-2.33 
PEG Ratio:-0.16 
Price to Sales:206.04 
Price to Book:-83.59 
Operating Margin:-73.19 
Return on Assets:-0.14 
Return on Equity:11.38 
EPS Ratio:-0.68 
Revenue:1.03M 
Shares:26.0M 
Market Cap:175.77M 

TECHNICAL INDICATORS

MA5:6.902.0%
MA10:7.6212.6%
MA20:7.419.6%
MA50:7.8215.7%
MA100:9.0734.2%
MA200:10.3553.1%
STO9:11.79 
STO14:11.79 
RSI14:48.70
WPR14:-87.01 
MTM14:-0.12
ROC14:-0.02 
ATR:0.71 
Week High:8.3623.7%
Week Low:6.405.6%
Month High:9.2336.5%
Month Low:6.4053.1%
Year High:20.30200.2%
Year Low:5.9813.0%
Volatility:27.82 

RECENT SPLITS

Date Ratio
05 Apr 20241-30